BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30003443)

  • 1. Effect of Inhalation Flow Rate on Mass-Based Plume Geometry of Commercially Available Suspension pMDIs.
    Moraga-Espinoza DF; Eshaghian E; Shaver A; Smyth HDC
    AAPS J; 2018 Jul; 20(5):84. PubMed ID: 30003443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Median Plume Angle: A novel approach to characterize plume geometry in solution based pMDIs.
    Moraga-Espinoza D; Eshaghian E; Smyth HDC
    Int J Pharm; 2018 May; 543(1-2):376-385. PubMed ID: 29635056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
    McCabe JC; Koppenhagen F; Blair J; Zeng XM
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to study the pMDI plume using an infrared camera and to evaluate the aerodynamic properties after varying the time between actuations.
    Kunda NK; Hautmann J; Godoy SE; Marshik P; Chand R; Krishna S; Muttil P
    Int J Pharm; 2017 Jun; 526(1-2):41-49. PubMed ID: 28450164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a holding chamber on albuterol metered-dose inhaler product differences.
    Johnson JL; Guthrie D; Hyde J; Hanson T; Karlage K; Myrdal PB
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):246-50. PubMed ID: 27613457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Exploration of Factors Affecting
    Ruzycki CA; Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):405-417. PubMed ID: 31418632
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers.
    Slator L; von Hollen D; Sandell D; Hatley RH
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S37-43. PubMed ID: 24476047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.
    Johal B; Murphy S; Tuohy J; Marshall J
    Adv Ther; 2015 Jun; 32(6):567-79. PubMed ID: 26100350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
    Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
    J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire.
    Hatley RH; Parker J; Pritchard JN; von Hollen D
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):71-79. PubMed ID: 27635793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Speed Laser Image Analysis of Plume Angles for Pressurised Metered Dose Inhalers: The Effect of Nozzle Geometry.
    Chen Y; Young PM; Murphy S; Fletcher DF; Long E; Lewis D; Church T; Traini D
    AAPS PharmSciTech; 2017 Apr; 18(3):782-789. PubMed ID: 27317571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for predicting size distributions delivered from pMDIs with suspended drug.
    Stein SW; Sheth P; Myrdal PB
    Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is "Slow Inhalation" Always Suitable for Pressurized Metered Dose Inhaler?
    Hira D; Okuda T; Mizutani A; Tomida N; Mizuno M; Ueshima S; Kakumoto M; Okano T; Okamoto H
    AAPS PharmSciTech; 2020 Jan; 21(2):53. PubMed ID: 31907655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonuniform Deposition of Pressurized Metered-Dose Aerosol in Spacer Devices.
    Ogrodnik N; Azzi V; Sprigge E; Fiset S; Matida E
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):490-500. PubMed ID: 27224033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.